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Background: Osteoarthritis (OA) is a leading cause of persistent pain and disability. Traditionally viewed as a slowly
progressive disease, the impact of symptom variability on prognosis remains unclear. ‘Acute-on-chronic’ episodes
are a well-recognised feature of many long-term conditions but only recently formally described in OA. This study
aimed to develop a web-based data collection platform and establish key methodological design parameters, to
develop a larger community-based study investigating acute flares of knee OA in England.
Methods: The study is a 9-week feasibility and pilot web-based observational case-crossover study. Adults aged ≥ 40 years
registered with two general practices who had consulted their general practitioner for knee pain/OA in the last 2 years were
recruited. Participants completed a baseline questionnaire and scheduled (control-period) questionnaires at follow-up weeks
1, 5, and 9. Participants were invited to self-declare via the website on any occasion they experienced a knee pain flare-up
lasting ≥ 24 h. Upon notification, an event-driven (case-period) questionnaire comparable to the scheduled questionnaires
was completed and daily measurements on the course and consequences were taken until resolution. A sub-study of 10
participants logged daily pain measurements. The analysis estimated key parameters including recruitment (selective non-
participation, eligibility, consent), retention, and flare-up capture processes. Questionnaire completeness and website usability
were evaluated.
Results: Of 442 patients invited, 14 completed baseline questionnaires. Eligibility rate was 26.9% (95% CI 19.3,
36.2), consent rate 53.6% (35.8, 70.5), and overall recruitment rate 3.2% (1.9, 5.2). Compared to those mailed,
baseline responders were more likely to be male and ≥ 65 years, as were those reporting ≥ 1 flare-up. Eleven
scheduled questionnaires were completed (mean response 35%). Although seven participants (50%) self-
declared 11 flare-ups, only one event-driven questionnaire was completed and three participants contributed daily
flare measurement for four flares. Missing data was ≤ 3.7% across completed baseline, scheduled, and event-driven
questionnaires. Aspects of website usability require minor refinement.
Conclusions: Recruitment was not feasible with the current strategy. An evaluation of processes has suggested several
substantial changes in design that may enhance recruitment, retention, and data quality in a future full-scale study.
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Osteoarthritis (OA) is a leading cause of disability in pop-
ulations worldwide [1]. In the UK each year, an estimated
4% of adults aged ≥ 45 years consult their general practice
with a recorded diagnosis of OA [2]—equating to more
than a million primary care consultations each year [3].
Osteoarthritis has typically been characterised as a pro-
gressive, non-inflammatory disease emerging from middle
age onwards in response to exposures earlier in life (e.g.
severe injury, cumulative excess mechanical loading), and
whose course is marked by slow, steady decline. Despite
this, there is increasing recognition that ‘acute-on-chronic’
episodes and ‘flare-ups’ of more severe pain are part of the
natural history [4–6], although fundamental questions re-
main unanswered about these phenomena.
Understanding flare-ups in OA is important for several
reasons: they can be distressing and disabling [4] and they
may drive patterns of intermittent healthcare use, includ-
ing over-the-counter analgesic and non-steroidal anti-
inflammatory use, primary care consultation, and
intra-articular injection. Dramatic changes in symptom se-
verity appear to disrupt healthy behaviours such as main-
taining a healthy weight and a physically active lifestyle,
which are regarded as important for the long-term man-
agement of OA [7]. In other long-term conditions, where
acute exacerbations are a recognised feature of the natural
history [8–12], research has provided important insights
into groups to target (e.g. ‘frequent exacerbator pheno-
type’ in Chronic Obstructive Pulmonary Disease (COPD)
[13–15]), as well as underpinning the discovery and evalu-
ation of effective biomedical [16] and behaviour change,
and service organisation [17] interventions.
Within a programme of research into flare-ups in OA,
we sought to design and undertake a full-scale web-based
case-crossover study to estimate proximate triggers of acute
flares in knee OA, determine their course and conse-
quences, and identify high-risk patient profiles that will dir-
ect future prevention and management for patients and
healthcare practitioners. Case-crossover studies [18] have
been used to good effect to identify triggers of other acute
health events (e.g. [19–21]), and researchers have begun
adopting this design to investigate episodic flare-ups of OA
[22]. However, there are a number of challenges and uncer-
tainties, including the ability to identify and recruit individ-
uals at risk of flare-ups to online data collection, efficient
and timely capture of these relatively short-lived and cur-
rently ill-defined events, and the ascertainment of relevant,
transient exposures. We undertook a feasibility and pilot
web-based observational case-crossover study with the pur-
pose of informing a future full-scale case-crossover study.
Overall aim
The overall aim of this feasibility and pilot study was
to establish important parameters and test severalprocesses that would inform the design of a future
web-based observational case-crossover study of acute
flares in knee OA.
Objectives
Specific objectives of the study were to:
i. Establish the feasibility of the recruitment strategy
(including willingness of patients to make the
transition from offline to online research
participation and evidence of selective non-
participation and retention)
ii. Clarify the suitability of the study eligibility criteria
iii. Establish the completeness of the data ascertained
iv. Estimate the proportion of participants reporting a
flare-up during a 9-week observation period
v. Explore the feasibility of processes for nesting
methodological sub-studies in a future full-scale study,
including the potential willingness of participants to
provide biomarker data
vi. Identify any improvements needed for functionality
and usability of the study website and email support
Methods
Study design and setting
This feasibility and pilot study is a community web-
based observational case-crossover study [18], a design
which focusses on within-person comparisons (‘Why
now?’ rather than ‘Why me?’ [23]), by comparing the
relative frequency of brief intermittent exposures (poten-
tial triggers) in periods just before transient acute health
events or episodes of interest [24, 25]. Applied in the
present context, the design seeks to estimate the direc-
tion and magnitude of associations between a range of
short-lived exposures and flare-ups of knee OA. By con-
ducting the study online, we hoped to have a relatively
low-cost design, capable of obtaining retrospective ex-
posure data as close as possible to the onset of a
flare-up, and of sampling (control-period) exposure fre-
quency among participants by repeated scheduled mea-
surements. Ethical approval for the study was obtained
from North East – York Research Ethics Committee
(REC Reference number: 16/NE/0390).
Participant identification and recruitment
Potentially eligible adults with knee OA were identified
and recruited from two local general practices in North
Staffordshire, England. Table 1 summarises the partici-
pant inclusion and exclusion criteria.
All eligible participants were mailed a study pack (invita-
tion letter on General Practice headed paper, participant in-
formation sheet (PIS), reply form with eligibility questions
and request for contact email address, and pre-paid return
envelope). Non-responders to the initial invitation were
Table 1 Eligibility criteria
Inclusion criteria Mode of ascertainment
Male or female aged ≥ 40 years GPSS
Registered as a permanent resident with participating general practices GPSS
Recorded consultation for knee OA or knee OA-related joint symptoms
in the last 2 years†
GPSS
Access to an email account and to the Internet PCRF
Exclusion criteria
Known diagnosis of inflammatory arthropathy, spondyloarthropathy, or
crystal arthropathy (e.g. rheumatoid arthritis, ankylosing spondylitis,
reactive arthritis, systemic lupus erythematosus, gout, psoriatic arthritis)†
GPSS
Recorded diagnosis of fibromyalgia† GPSS
Red flags: recent significant trauma to knees; acutely hot swollen joint GPSS, PCRF
Previous total knee arthroplasty or on waiting list for total knee arthroplasty GPSS, PCRF
Corticosteroid injection into the knee in the last 3 months PCRF
Surgery to either knee within the past 3 months GPSS, PCRF
Unable to complete questionnaires written in English via the study website PCRF
Vulnerable individuals (e.g. psychiatric illness, learning difficulties, dementia,
terminal illness, and severe enduring mental ill health)
GPSS
GPSS general practice search and screen, PCRF patient-completed reply form
†Based on code lists (available at http://www.keele.ac.uk/mrr/morbiditydefinitions/)
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completed reply form, fulfilled the eligibility criteria, and
provided a valid personal email address were sent a wel-
come email containing a link to the study website, which
was hosted on a secure network. Eligible participants acces-
sing the link were asked to confirm they had read and
understood the PIS and were then invited to provide in-
formed electronic consent (e-Consent) to take part in the
study. Consenting participants were directed to a login page
to set up their unique username and password.
Data collection
Data collection comprised four main strands: a baseline
questionnaire to collect descriptive characteristics from
participants, scheduled questionnaires to collect infor-
mation on exposure frequency on days not followed by a
flare-up, event-driven questionnaires to collect informa-
tion on flare-ups and exposure frequency on the days
prior to a flare-up, and ultra-short daily flare-up ques-
tionnaires to be completed following flare notification
until its resolution. Once any questionnaire was com-
pleted and submitted, participants had no repeat access
to their answers. All questionnaires had to be completed
at one time point, and there was no facility for partial
completion and return at a later time.
Baseline questionnaire
Upon activating a website login, participants were di-
rected to the baseline questionnaire (although they could
opt to complete this later via an emailed web link) andsent a welcome email including information about log-
ging in and how to self-report a flare-up (see below).
Email reminders were sent to participants who had not
completed their baseline questionnaire after 3 days and
again after a further 3 days. On day 8, the questionnaire
became deactivated and an email was sent notifying par-
ticipants that they could not continue in the study.
Table 2 presents the baseline questionnaire content.
Scheduled (control-period) questionnaires
A scheduled control-period questionnaire (Table 2) asking
questions about selected exposures during the last 7 days
was sent to participants via an emailed web link 1 week,
5 weeks, and 9 weeks after completion of the baseline
questionnaire. At the same time each questionnaire also
became accessible on the study website, should partici-
pants login to the website independently. For scheduled
control-period questionnaires, we followed the same
process of email reminders and deactivating the question-
naire as per baseline questionnaire except that after de-
activation, participants continued through the study to the
next scheduled follow-up questionnaire.
The first question of the scheduled control-period ques-
tionnaire asked participants if they felt they were currently
experiencing a flare-up. If they responded ‘yes’ to this ques-
tion, they were immediately redirected to complete an
event-driven questionnaire (see the ‘Event-driven (case-
period) questionnaires’ section below). If participants indi-
cated they were exposed to any of the selected exposures,
they were taken to a calendar template to determine the date
Table 2 Study questionnaires
Concept Measurement method Detail Time available for
completion
Reminder
sent
Baseline questionnaire
Section A: knee
pain
Duration Pain in last 12 months. Left, right 7 days Yes
Time since onset < 1 year, 1–4 years, 5–9 years, 10+ years.
Left, right
Pattern [36] 5 flare pattern illustrations. Left, right
Experience of knee pain [37] In past 6 months: no pain, predictable
pain, some unpredictability, constant.
Left, right
Walking difficulty [38] Injury induced walking problems for at
least 1 week. Left, right
Pain, aching, stiffness in last month [39, 40] No days, few days, some days, all days.
Left, right
Worst/least in last week, average, current [41] 0–10 NRS with anchors (no pain, pain as
bad as you can imagine)
Flare-up at present Yes/no. Left, right
Self-reported main flare trigger Free text
Bothersomeness in last 24 h [42] Not at all, slightly, moderately, very much,
extremely. Left, right
Leg angles [43] Very bow legged, bowed legged, normal,
knock-knee, very knock-knee. Left, right
Foot angles [43] Very turned out feet, turned out feet, straight,
turned in feet, very turned in feet. Left, right
KOOS-PS [44] 7-item and 5-option categories for difficulties
with daily activities in last week
KOOS-Qol [45] 4-item and 5-option categories for quality of
life in last week
Medications for knee pain, last week
Health professional consultation for knee
pain, last year
17-option categories for drug use
General practitioner, practice/district nurse,
physiotherapist, surgeon, rheumatologist,
acupuncturist, occupational therapist.
Section B: general
health
Perceived general health [46]
Physical activity(GPPAQ) [47]
Excellent, very good, good, fair, poor
Work physical activity (5-response options),
general physical activity in last week
(5-response options, 4-option categories),
walking pace
Self-reported weight Stones/lbs. or kg
Self-reported height Feet/inches or cm
Section C:
demographics
Gender
Date of birth
Current employment
Male/female
Date/month/year
Paid employment or self-employed, retired,
looking after home and/or family, unable to
work because of sickness or disability,
unemployed, doing unpaid or voluntary
work, full or part-time student
Scheduled (control-period) and event-driven (case-period)
questionnaires*
Knee pain Flare-up at present Yes/no. Left, right 7 days/ 2 days Yes
Average pain in last 24 h [27] 0–10 NRS with anchors (no pain, pain as
bad as you can imagine). Left, right
Changes noticed
since flare-up†
Limping, swelling, stiffness, increased difficulty
with activities of daily living, sleep disturbed
by knee pain
Tick as many boxes as apply
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Table 2 Study questionnaires (Continued)
Concept Measurement method Detail Time available for
completion
Reminder
sent
Physical activities Vigorous physical activity > 10 mins [48] Yes/no
Climbing several flights of stairs Yes/no
Repetitive or prolonged squatting Yes/no
Repetitive or prolonged kneeling Yes/no
Climbing up and down ladders Yes/no
Lifting or moving heavy objects Yes/no
Prolonged periods of sitting without a break Yes/no
Prolonged periods of standing without a break Yes/no
Any unusual activities involving knees Yes/no
Slips, trips, sprains,
strains
Slip, trip, or fall
Episode of buckling or giving way [49]
Yes/no
Yes/no. Left, right
Health and
healthcare
Reduce or miss medication
Take extra medication
Yes/no
Yes/no
Cough, cold, other minor infection Yes/no
Stress and other
things
Work related stress [50]
Home related stress [50]
Yes/no
Yes/no
Friend/family-related stress [50] Yes/no
Low mood/depression Yes/no
Feeling angry, irritable, hostile Yes/no
Poor night’s sleep Yes/no
Eat foods usually avoided Yes/no
Cold/damp weather Not at all, slightly, moderately, severely,
extremely
Day of above
exposure
All yes responses from above sections (physical
activity; slips, trips, sprains, strains; health and
healthcare; stress and other things) anchored
to day of the week
Grid of previous 7 days from declared
flare-up onset. Tick as many boxes as
apply
Brief daily questionnaire during flare-up
Knee pain Average pain in last 24 h [27] 0–10 NRS with anchors (no pain, pain as
bad as you can imagine). Left, right
6 h No
Impact of pain Bothersomeness in last 24 h [42] Not at all, slightly, moderately, very much,
extremely. Left, right
Medication use Pain medication taken in last 24 h No; yes, but less than usual; yes, but about
the same as usual; yes, more than usual
Flare-up resolution Has your flare-up ended Yes/no
Brief daily questionnaire for sub-study
Main flare-up
trigger
Did your main trigger for a flare-up of knee
pain [baseline response reminder] happen
today
Yes/no 6 h No
Knee pain Average pain in last 24 h [27] 0–10 NRS with anchors (no pain, pain
as bad as you can imagine). Left, right
KOOS-PS Knee injury and Osteoarthritis Outcome Score-Physical Function Short Form, Qol qualify of life, GPPAQ General Practice Physical Activity Questionnaire,
NRS numerical rating scale
*Control-period questionnaires scheduled for week 1, 5, and 9 post-baseline completion; event-driven questionnaires initiated by participant if and when
flare-ups occur
†Question applied to event-driven questionnaires only
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from the present date, and participants were invited to select
which days over this period they were exposed to each of
their selected exposures.Event-driven (case-period) questionnaires
Participants were invited to complete an event-driven
flare-up case-period questionnaire immediately, at any
point if they provided notification through the study
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This was either via a web link provided in previous email
correspondence (welcome and scheduled questionnaire
emails) or by logging onto the study website and clicking
a prominent flare notification icon. Participants were
given the option to complete the questionnaire immedi-
ately or later by requesting an emailed web link to the
questionnaire. The first question of the event-driven
questionnaire asked participants to enter the date the
flare-up started. If it was ‘today’, an onscreen notification
was generated thanking participants before inviting them
to notify us again tomorrow should their flare-up persist
for 24 h. If it was 4 or more days previously, an onscreen
notification was generated thanking the participant for
their notification and informing them that there was no
requirement for an event-driven questionnaire to be
completed at this time. These participants were still in-
vited to complete a short daily questionnaire via email
until the resolution of their flare-up episode (see the
‘Daily flare-up questionnaires’ section below). If the
flare-up started within the last 3 days, questions about
activities during the last 7 days were taken from the date
of onset. The system included the appropriate days of
the week for each of the last 7 days of questioning to aid
recall. If participants did not respond, an email reminder
was sent after 1 day. If non-response continued, a repeat
email reminder was sent after a further 1 day. If no re-
sponse was received after 2 days, on day 3, the question-
naire became deactivated. Participants were notified of
this by email. If participants did not complete an
event-driven questionnaire, they continued through the
study to the next scheduled follow-up questionnaire.
The content of the event-driven questionnaires was
identical to the scheduled control-period questionnaire
with the following exceptions: there was no question on
flare-up at present, and there were questions on the
knee affected by a current flare. These included changes
noticed since the flare-up—limping, swelling, stiffness,
increase difficulty with activities of daily living, and sleep
disturbed by knee pain (Table 2).
Brief daily questionnaires during flare-up
Following completion of an event-driven questionnaire,
the next day, participants were invited by email to an-
swer brief daily questions about the flare-up (Table 2)
until participants’ self-reported that their symptoms had
returned to their pre-flare ‘normal’ state for 2 consecu-
tive days. There were no daily reminders, and questions
could only be completed on the day of invitation, with
any earlier incomplete dates being deactivated. Emails
were sent at 18:00 Greenwich Mean Time (GMT) and
remained open until 23.59 each day for the duration of
the flare-up episode. End-of-day reporting of pain has
previously been shown to adequately represent averagepain levels across the same day [26]. Participants still ex-
periencing a flare-up at the end of the study period were
not followed up beyond this time point.
Nested methodological sub-study questions
A nested sub-study involved the first 10 enrolled partici-
pants, who were invited to answer additional brief daily
questions for the 9-week study period. These commenced
following completion of the baseline questionnaire. The
purpose of this sub-study was to obtain prospective data
that could be examined relative to the retrospective data
collected within the main scheduled and event-driven ques-
tionnaires. Questioning for each participant was individua-
lised, based on their response in the baseline questionnaire
about what they personally perceived to be their main trig-
ger for a flare-up of knee pain. Brief questioning also asked
about pain intensity in the last 24 h [27] (Table 2). There
were no daily reminders, and questions could only be com-
pleted on the day of invitation, with any earlier incomplete
dates being deactivated. If participants attempted to click
on any out-of-date email links, they were automatically
taken to the current day’s questionnaire, or directed to
complete future questionnaires at the next appropriate time
point. Emails were sent at 18:00 GMT and remained open
until 23.59 each day for the duration of study.
Upon study completion, participants were asked
whether, in principle, they would be willing to provide
additional biomarker data through magnetic resonance
imaging (MRI) and/or the provision of a synovial fluid
sample via knee joint aspiration during a flare-up.
Objective weather data downloaded from the UK Me-
teorological Office for the study period supplemented
subjective weather-based questioning.
Patient involvement
Our study was a patient-confirmed research priority. A
patient advisory group (PAG) assisted with the question-
naire content, website development, and post-study
evaluation in the following ways: group workshops, writ-
ten and verbal feedback of questionnaires and patient fa-
cing documentation, practical hands-on trials during
website development, participation in website video clips
of flare-up description, and interpretation of data. One
member of the PAG also actively contributed as a mem-
ber of the study management group (CP).
Outcome definition
Our working definition of a self-reported flare-up of
symptomatic knee OA was ‘an event in the natural
course of the condition, characterised by a change in the
patient’s baseline pain that is beyond normal day-to-day
variation, sustained for at least 24 hours, and is sudden
or quick in onset. It may impact on the ability to per-
form everyday activities and have resulted in an increase
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to definition, self-assessment, and the definition itself
was informed by a previous systematic literature review
[unpublished data at time of submission], group discus-
sions with patients and members of the public, and find-
ings from an earlier survey and 3-month pen-and-paper
daily diary study [unpublished data at time of
submission].
Sample size
Based on our recently completed pen-and-paper daily
diary study in a similar patient population and sample
frame, and an assumed combined response and consent
rate of 12%, we estimated 400–450 eligible participants
would need to be screened from up to four average-sized
general practices to provide the target sample of 50 partic-
ipants deemed sufficient for the study objectives.
Statistical analysis
As a feasibility and pilot study, the statistical analysis
plan focussed on process measures and evaluative
methods to inform a future full-scale study. A flowchart
summarised the recruitment and retention of partici-
pants into the study, and descriptive statistics were used
to estimate recruitment, eligibility, consent, and reten-
tion rates and to examine the extent of selective
non-participation and the quality and completeness of
the data ascertained across all study time points.
To examine and quantify the effect of self-reported re-
call bias of exposure triggers, comparative objective data
collection was planned for one variable. Weather-based
questioning asked at each scheduled and event-driven data
collection time point could be compared with objective
weather data downloaded from the UK Meteorological
Office for the same period. This step can explore the feasi-
bility of providing additional quantitative estimates adjust-
ing for any inherent self-reporting recall bias.
All analyses were conducted using STATA V.14 (Stata
Corporation, TX, USA).
Results
Study population
During March and April 2017, 442 adults aged 40 years
and over were mailed a study invitation (Fig. 1). In total,
104 reply forms were received (crude response 23.5%
(95% confidence intervals (CI) 19.8, 27.7)), of whom 28
were deemed eligible (eligibility rate among responders
26.9%; 19.3, 36.2) and 15 consented (consent rate among
eligible responders 53.6%; 35.8, 70.5), all of whom regis-
tered an online account on the study website. There were
311 non-responders to invitation. In total, 14 people com-
pleted a baseline questionnaire, producing an overall re-
cruitment rate of 3.2% (1.9, 5.2). Two participants
withdrew from the study, one following completion of thebaseline questionnaire and one following the week 1
scheduled questionnaire. Eight participants completed at
least one scheduled follow-up. Using this as a follow-up
indicator, estimated retention was 57.1% (32.6, 78.6).Selective non-participation
Compared with the initial mailed population, baseline
responders appeared more likely to be male and aged ≥
65 years (Table 3). There were insufficient numbers to
meaningfully evaluate participant characteristics related
to post-baseline attrition.Completeness and quality of data ascertained
Levels of missing item-level data were low among those
participants who began each type of questionnaire. Of
the 14 participants who began the baseline question-
naire, the median number of missing responses was 2 of
94 items (range 0–12). With the exception of one item
for one participant, there were no missing item-level
data from the 11 scheduled questionnaires completed by
eight participants. The sole event-driven questionnaire
that was completed had responses to only five of the
physical activity exposure questions missing.
Eleven flare-up notifications were reported by seven
participants during the study period (Table 4). Only one
participant-reported flare-up met the study case defin-
ition and was therefore eligible to complete the flare-up
questionnaire. For those who completed the daily
flare-up questionnaire, two were monitored to reso-
lution. These ended seven, and 23 days after the date,
the flare-up was reported.Nested methodological sub-studies
For the first 10 participants recruited into the study, an
exposure question was asked about their self-reported
main trigger, together with daily measurements of knee
pain for the 9-week study period. Four participants did
not respond to any of the daily sub-study questionnaires,
with the remaining six participants completing between
23 and 50 daily questionnaires from a possible 63
(Table 5). For two participants, there appeared little or
no day-to-day variability in exposure to their main re-
ported trigger during the study period.
Six participants returned a post-study evaluation ques-
tionnaire. Four expressed willingness, in principle, to
have an MRI scan during a flare-up, and two confirmed
willingness to undergo a knee joint aspiration during a
flare-up, as part of a future study.
There was insufficient response to both the scheduled
and event-driven questionnaires to run an analysis to
evaluate the comparison of subjective weather recall
with objective UK Meteorological Office weather data.
Fig. 1 Flowchart of participants recruited into study
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Table 3 Gender and age differences between exclusions, non-responders, and responders at each time point
All mailed
participants
(N = 442)
Non-responders
and refusals
(N = 338)
Exclusions
(N = 76)
Eligible
(N = 28)
Eligible but
dropped out
(N = 14)
Baseline
responders
(N = 14)
Responders to at
least one scheduled
follow-up (N = 8)
Reported
flares (N = 7)
Gender
Males 199 (45) 152 (45) 30 (40) 17 (61) 8 (57) 9 (64) 6 (75) 5 (71)
Females 243 (55) 186 (55) 46 (61) 11 (39) 6 (43) 5 (36) 2 (25) 2 (29)
Age
40–54 129 (29) 108 (32) 13 (17) 8 (29) 5 (36) 3 (21) 0 (0) 0 (0)
55–64 125 (28) 99 (29) 16 (21) 10 (36) 6 (43) 4 (29) 4 (50) 2 (29)
65+ 188 (43) 131 (39) 47 (62) 10 (36) 3 (21) 7 (50) 4 (50) 5 (71)
Age, males
40–54 64 (32) 52 (34) 6 (20) 6 (35) 4 (50) 2 (22) 0 (0) 0 (0)
55–64 61 (31) 47 (31) 7 (23) 7 (41) 4 (50) 3 (33) 3 (50) 2 (40)
65+ 74 (37) 53 (35) 17 (57) 4 (24) 0 (0) 4 (44) 3 (50) 3 (60)
Age, females
40–54 65 (27) 56 (30) 7 (15) 2 (18) 1 (17) 1 (20) 0 (0) 0 (0)
55–64 64 (26) 52 (28) 9 (20) 3 (27) 2 (33) 1 (20) 1 (50) 0 (0)
64+ 114 (47) 78 (42) 30 (65) 6 (55) 3 (50) 3 (60) 1 (50) 2 (100)
Absolute numbers and percentages are provided
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This feasibility and pilot study has proved valuable for
improving and refining processes and procedures for a
future full-scale study. The study recruitment method,
eligibility criteria, and processes to facilitate follow-up
retention and enable flare notification, together with
some key aspects of the web-based functionality and us-
ability, require modification and refinement for a future
full-scale study.
Key findings and design implications for a full-scale study
Identification and recruitment of participants
By using primary care general practice registers, we were
able to identify sufficient potentially eligible participants;Table 4 Descriptive characteristics of flare-up capture and monitorin
Participant ID Flare number Flare captured by
which questionnaire
Flare-up met study
definition; reason if n
XX526 1 Event-driven No Flare reported
2 Scheduled (week 9) No Flare reported
XX581 1 Scheduled (week 5) – Day of onset m
2 Scheduled (week 9) No > 3 days since
XX637 1 Event-driven No > 3 days since
XX041 1 Event-driven No Flare reported
XX065 1 Scheduled (week 5) No > 3 days since
2 Scheduled (week 9) No > 3 days since
XX706 1 Event-driven No Flare reported
XX160 1 Event-driven No Flare reported
2 Event-driven Yes –however, the proportion of non-responders to invitation
was high (331/442 (70%)), for reasons unknown. The
proportion of mailed participants enrolled into the study
was 14/442 (3.2%). This recruitment rate is notably less
than the 12% response from our recent pen-and-paper
diary study (unpublished data) and appears relatively in-
efficient. Previous studies have demonstrated that con-
current pen-paper or Internet questionnaire completion
options do not result in better response rates [28, 29];
however, the loss of eligible potential participants due to
the requirement to transition from offline to online is
one plausible contributing factor for our low response.
By approaching people via post, the extent to which
people may have chosen not to express interest in thisg
ot
Flare ended Completed flare-up
questionnaire
on day of onset – –
on day of onset – –
issing Missing –
flare onset Unresolved –
flare onset – –
on day of onset – –
flare onset 23 days after date flare reported –
flare onset Unresolved –
on day of onset – –
on day of onset – –
7 days after flare reported Yes
Table 5 Daily pain measurements
Participant ID Number of days
questionnaire
completed*
Number of days
main trigger
reported
Verbatim self-reported main trigger Daily left knee
pain severity
Median (IQR)
Daily right knee
pain severity
Median (IQR)
XX526 27 11 Rising from sitting position 0 (0, 2) 0 (0, 2)
XX581 44 43 Stiff walking/pressure 1 (1, 1) 3 (2, 4)
XX592 49 6 Physical activity, cold damp weather 2 (1, 3) 2 (1, 3)
XX595 23 9 If I kneel down on it 0 (0, 0) 2 (0, 4)
XX599 0 – ‘Jarring’ of knee due to tiredness/stiffness
following exercise
– –
XX637 0 – I do not know, but think it may be the
weather
– –
XX669 0 – Cold damp weather, excess housework
and gardening
– –
XX701 0 – Cannot pin point it – –
XX041 42 0 Over activity 1 (0, 1) 1 (0, 1)
XX065 50 41 I find that my knee pain can come at any
time. I do the same things everyday but
some days it is a bit more difficult to do
as the pain gets in the way.
6 (5, 6) 6 (5, 7)
IQR interquartile range
*Participants were able to fill in the daily questionnaire for a maximum of 63 days
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known. Supplementing this approach with offline com-
munity advertising and/or online social media advertis-
ing, directing people to a self-enrolment page on the
study website, may help to target individuals who are
more inclined or willing to take part in online research
[30, 31]. In terms of generating the sample, these parallel
processes could facilitate recruitment of individuals from
across wider geographical locations. Over-zealous exclu-
sion criteria contributed to lower recruitment. Close in-
spection of our eligibility criteria indicated that we
subsequently deemed 76 potential participants ineligible
for a combination of the following reasons: current hot
swollen knees, knee injury in the last 3 months bad
enough to see a doctor, knee replacement or on waiting
list, corticosteroid injection into the knee in the last
3 months, and knee surgery in the last 3 months. Had
we relaxed these exclusion criteria and accepted into the
study all people who (i) met the general practice search
and screen inclusion criteria and (ii) had daily access to
email and the Internet and could complete question-
naires in English, this would have yielded a revised eligi-
bility rate of 66.4% (95% CI 56.8, 74.7). Expecting that
approximately half of these individuals would provide
e-Consent and complete a baseline questionnaire, the re-
vised estimate for overall recruitment rate would be
7.9% (95% CI 5.8, 10.8).
People with hot swollen knees were excluded on the
basis that these characteristics may represent more acute
red flag presentations such as sepsis or other arthritis
conditions. Assuming that such occurrences will be rarewithin a community-based sample, this criterion could
have been relaxed. Furthermore, people with OA who
have warm knees who experience swelling may be indi-
viduals more likely to experience flare-ups [32]. Al-
though our other eligibility criteria improve the
homogeneity of the sample with regard to knee charac-
teristics, an alternative strategy for a future full-scale
study would invite all of the 69 interested potential par-
ticipants and subsequently evaluate the impact of these
criteria with sensitivity analyses.
The technical process of obtaining e-Consent was ad-
equate, and there were no reported problems with func-
tionality. Five participants opted not to provide consent,
and a further eight did not respond to the welcome
email for reasons unknown. To encourage e-Consent
completion and enrolment among those who initially ex-
press interest, a reminder email could be built into a fu-
ture full-scale study. A small number of participants
experienced difficulties accessing the website during
early stages of the study, and their issues were handled
in real-time. These issues contributed to the decision
made by two consenting participants to withdraw from
the study.
Retention, follow-up, and flare-up notification
Based on completing one scheduled follow-up question-
naire, retention was 57%. However, the overall symptom
severity of the sample was mild and had we included
people experiencing hot swollen knees, their increased
symptoms may have led to more flare-up notifications
and general engagement with the study.
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pants experiencing a flare-up at a scheduled follow-up
proved effective. For the flare-up notification process
more broadly, our procedures may have impeded some
participants’ ability to report flare-ups. Four participants
reported a flare on the day of onset. They then received
an automated response inviting them to return the next
day to ensure their flare-up lasted for 24 h. None of
these participants returned the next day. It is impossible
to know whether this is due to resolution of symptoms
or failure to return to the website. The decision to invite
participants to complete an event-driven questionnaire if
flare-up onset was within 3 days was designed to aid re-
call of the last 7 days from onset. It may have been more
appropriate to allow all participants to complete an
event-driven questionnaire on the day a flare-up is re-
ported, then apply a case definition, such as sustained
for at least 24 h, by using the daily flare questionnaire
data during analysis. This more pragmatic approach
would be acceptable given that there is currently no
agreed knee OA flare-up definition within the OA com-
munity [6]. It would appear that more participants
wished to notify us of a flare-up than were recorded dur-
ing the study period, although it cannot be ruled out
that some participants may have logged a flare in error.
For example, by clicking on the flare notification icon
whilst exploring the website. An ‘are you sure?’ function
could be added at this point to reduce the potential for
people to report flare-ups inadvertently. Whilst the over-
all recorded proportion of flare-related contacts was en-
couraging at 50%, nearly half of the flare-ups were
reported at scheduled follow-up time points; hence, the
capture of flare data may be enhanced with a more ef-
fective reminder process, for example by sending
bi-weekly text message reminders for the study duration.
Data quality and methodological sub-studies
The decision to include a daily measurement sub-study was
designed to enable sensitivity analysis relating to the poten-
tial for recall bias between the scheduled and event-driven
questionnaire comparisons. By capturing additional daily
prospective pain scores, these data could be compared to
the retrospectively reported data within the main analysis
to quantify the amount of potential bias that could be at-
tributed to recall. Given the poor retention over the study
period, it is possible that this extra burden of engagement
could have adversely affected follow-up. If this process was
removed from a full-scale study, recall and recall bias could
be handled with other less-burdensome techniques. Firstly,
by reducing the recall period from the last 7 days to the last
3 days: This would help with the general cognitive effort re-
quired to accurately recall issues over the last few days and
may also improve response at scheduled follow-up time
points. Secondly, by adding ‘normal’ frequency of exposureto the baseline questionnaire for key potential triggers being
investigated, an additional control sample could be gener-
ated to compare against the case period. This would mean
that multiple control sampling strategies are incorporated
into the design. These could include within-person
case-crossover comparisons between the day before the
flare-up started in the flare-up questionnaire (case-period)
and three control-period samples: (i) the 2 days prior in the
event-driven questionnaire, (ii) 1 or more 3-day periods
within the scheduled questionnaire(s), or (iii) the normal
frequency of exposure in the baseline questionnaire [33].
These could be compared and contrasted with sensitivity
analyses to examine the potential influence of recall bias,
and the optimal control period selected as the one that
maximises the exposure odds ratio [34]. This approach
could also negate the need to evaluate recall bias using ob-
jective weather data, which could not be evaluated in our
study. Poor retention and engagement over a 9-week period
also indicates that high-quality case-control comparisons
may be more efficiently obtained by increasing sample size
over a short period of follow-up, rather than a more ex-
tended period. A further advantage of the case-crossover
design is that the data can be analysed as a cohort study
when ‘normal’ frequency of exposure at baseline is
collected.
Although the number of people responding to the
post-study questionnaire was small (n = 6), more people
expressed willingness to receive an MRI scan during a
flare-up (n = 4), rather than a joint aspiration (n = 2).
This observation may reflect the more invasive nature of
joint aspiration.
Strengths and limitations
Major strengths of this study were patient involvement
and the use of clinician and patient meetings for inter-
preting the findings and evaluating whether and how to
transition to full-scale study. A limitation was the web-
site’s incompatibility with smartphone use. This may
have restricted the flexibility of questionnaire comple-
tion. A future full-scale study could benefit from smart-
phone compatibility, which may improve follow-up
retention, particularly for the brief daily questionnaires
during flare-up periods. Six participants reported a
flare-up at baseline. This may have affected the way their
general health-related questions were completed. Con-
ducted on a larger scale, the impact of this on any de-
rived estimates would need to be quantified with
sensitivity analyses. Finally, our understanding of why
people chose not to participate may have been enhanced
further had we included a nested qualitative study.
Conclusions
Feasibility and pilot studies are most typically under-
taken in the context of developing full-scale intervention
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studies too, particularly where there are important un-
certainties in their design and implementation. In this
study, our recruitment rate of 3% is substantially lower
than comparable rates for offline questionnaire-based
studies. Proposed solutions to this were suggested by an
evaluation of process in the current study and from pre-
vious relevant studies. However, the outcome of imple-
menting these in future full-scale study is necessarily
uncertain.
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